Protective effect of florfenicol on acute lung injury induced by lipopolysaccharide in mice

International Immunopharmacology

Volumn 9, Issue 13-14, 2009, Pages 1525-1529

  Zhang, Xuemei ^a,b   Song, Keji ^a   Xiong, Huanzhang ^b   Li, Hongyu ^a   Chu, Xiao ^a   Deng, Xuming ^a  

^a JILIN UNIVERSITY   (China)

^b YANBIAN UNIVERSITY   (China)

Author keywords

Acute lung injury; Florfenicol; LPS

Indexed keywords

CYTOKINE; DEXAMETHASONE; FLORFENICOL; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DRUG EFFECT; HISTOPATHOLOGY; IN VIVO STUDY; LUNG LAVAGE; LUNG TOXICITY; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY;

ACUTE LUNG INJURY; ADMINISTRATION, ORAL; ANIMALS; ANTIBIOTIC PROPHYLAXIS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CYTOKINES; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; NEUTROPHILS; THIAMPHENICOL;

EID: 70350754327     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.09.007     Document Type: Article

References (25)

1. Ware L.B., and Matthay M.A. The acute respiratory distress syndrome. N Engl J Med 342 (2000) 1334-1349
2. Bhatia M., and Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202 (2004) 145-156
3. Lee W.L., and Downey G.P. Neutrophil activation and acute lung injury. Curr Opin Crit Care 7 (2001) 1-7
4. Bosma K., Fanelli V., and Ranieri V.M. Acute respiratory distress syndrome: update on the latest developments in basic and clinical research. Curr Opin Anaesthesiol 18 (2005) 137-145
5. MacCallum N.S., and Evans T.W. Epidemiology of acute lung injury. Curr Opin Crit Care 11 (2005) 43-49
6. Jain R., and DalNogare A. Pharmacological therapy for acute respiratory distress syndrome. Mayo Clin Proc 81 (2006) 205-212
7. Shin S.J., Kang S.G., Nabin R., Kang M.L., and Yoo H.S. Evaluation of the antimicrobial activity of florfenicol against bacteria isolated from bovine and porcine respiratory disease. Vet Microbiol 106 (2005) 73-77
8. Priebe S., and Schwarz S. In vitro activities of florfenicol against bovine and porcine respiratory tract pathogens. Antimicrob Agents Chemother 47 (2003) 2703-2705
9. Aslan V., Maden M., Erganis O., Birdane F.M., and Corlu M. Clinical efficacy of florfenicol in the treatment of calf respiratory tract infections. Vet Q 24 (2002) 35-39
10. Ueda Y., Ohtsuki S., and Narukawa N. Efficacy of florfenicol on experimental Actinobacillus pleuropneumonia in pigs. J Vet Med Sci 57 (1995) 261-265
11. O'Connor A.M., Wellman N.G., Evans R.B., and Roth D.R. A review of randomized clinical trials reporting antibiotic treatment of infectious bovine keratoconjunctivitis in cattle. Anim Health Res Rev 7 (2006) 119-127
12. Angelos J.A., Dueger E.L., George L.W., Carrier T.K., Mihalyi J.E., Cosgrove S.B., et al. Efficacy of florfenicol for treatment of naturally occurring infectious bovine keratoconjunctivitis. J Am Vet Med Assoc 216 (2000) 62-64
13. Zhang X., Song Y., Ci X., An N., Fan J., Cui J., et al. Effects of florfenicol on early cytokine responses and survival in murine endotoxemia. Int Immunopharmacol 8 (2008) 982-988
14. Szarka R.J., Wang N., Gordon L., Nation P.N., and Smith R.H. A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation. J Immunol Methods 202 (1997) 49-57
15. Meduri G.U., Tolley E.A., Chrousos G.P., and Stentz F. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med 165 (2002) 983-991
16. Beck B.D., Brain J.D., and Bohannon D.E. An in vivo hamster bioassay to assess the toxicity of particulates for the lungs. Toxicol Appl Pharmacol 66 (1982) 9-29
17. Abraham E. Neutrophils and acute lung injury. Crit Care Med 31 4 Suppl (2003) S195-S199
18. Cepkova M., and Matthay M.A. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med 21 (2006) 119-143
19. Weinacker A.B., and Vaszar L.T. Acute respiratory distress syndrome: physiology and new management strategies. Annu Rev Med 52 (2001) 221-237
20. Staub Sr. N.C., Longworth K.E., Serikov V., Jerome E.H., and Elsasser T. Detergent inhibits 70-90% of responses to intravenous endotoxin in awake sheep. J Appl Physiol 90 (2001) 1788-1797
21. Sone Y., Serikov V.B., and Staub Sr. N.C. Intravascular macrophage depletion attenuates endotoxin lung injury in anesthetized sheep. J Appl Physiol 87 (1999) 1354-1359
22. Giebelen I.A., van Westerloo D.J., LaRosa G.J., de Vos A.F., and van der Poll T. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock 28 (2007) 700-703
23. Goodman R.B., Pugin J., Lee J.S., and Matthay M.A. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 14 (2003) 523-535
24. Minamino T., and Komuro I. Regeneration of the endothelium as a novel therapeutic strategy for acute lung injury. J Clin Invest 116 (2006) 2316-2319
25. Fan J., Ye R.D., and Malik A.B. Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol 281 (2001) L1037-L1050